What are the statistical implications of treatment non-compliance in cluster randomized trials: A simulation study.
Clicks: 237
ID: 95812
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
237 views
25 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #16 of 21 articles by views in Statistics in Medicine
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Subjects in randomized controlled trials do not always comply to the treatment condition they have been assigned to. This may cause the estimated effect of the intervention to be biased and also affect efficiency, coverage of confidence intervals, and statistical power. In cluster randomized trials non-compliance may occur at the subject level but also at the cluster level. In the latter case, all subjects within the same cluster have the same compliance status. The purpose of this study is to investigate the statistical implications of non-compliance in cluster randomized trials. A simulation study was conducted with varying degrees of non-compliance at either the cluster level or subject level. The probability of non-compliance depends on a covariate at the cluster or subject level. Various realistic values of the intraclass correlation coefficient and cluster size are used. The data are analyzed by intention to treat, as treated, per protocol and the instrumental variable approach. The results show non-compliance may result in downward biased estimates of the intervention effect and an under- or overestimate of its standard deviation. The coverage of the confidence intervals may be too small, and in most cases, empirical power is too small. The results are more severe when the probability of non-compliance increases and the covariate that affects compliance is unobserved. It is advocated to avoid non-compliance. If this is not possible, compliance status and covariates that affect compliance should be measured and included in the statistical model.
| Reference Key |
moerbeek2019whatstatistics
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Moerbeek, Mirjam;Schie, Sander van; |
| Journal | Statistics in Medicine |
| Year | 2019 |
| DOI |
10.1002/sim.8351
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.